CC BY
15
Kovalenko Sergiy, Doctor of chemical sciences, professor, Department of Organic Chemistry, V. N. Karazin Kharkiv National University, 4 Svobody Sq., Kharkiv, Ukraine, 61022 E-mail: kovalenko. sergiy.m@gmail.com
Kovalenko Svitlana, Candidate of chemical sciences, associate professor, Department of Quality Management, National University of Pharmacy, 53 Pushkinska str., Kharkiv, Ukraine, 61002 E-mail: claire82@mail.ru
UDC 615.012:615.28]-092.4
DOI: 10.15587/2313-8416.2016.65209
SYNTHESIS OF THE ROW OF NEW FUNCTIONAL DERIVATIVES OF 7-ARYLALKYL -8-HYDRAZINE THEOPHYLLINES
© D. Korobko
Hydrazine functional derivatives are widely used in medical practice as remedies applied for pharmacotherapy of depression, infection diseases, hypertension, diabetes, etc. It is worth mentioning that among obtained 7-R-8-hydrazine derivatives of 1,3-dimethylxantine promising substances have been identified. Due to the fact that literature sources display only results of occasional studies of the reactions between 7-R-8-hydrazine theophyllines and mono- or dicarbonyle substances, the use of other keto reagents for xanthine bicycle at 8th position function-alization will allow to explore synthetic potential of the last one, and with high probability may lead to obtaining original biologically active substances.
Aim. To study types of reaction between 8- hydrazinyl-1,3-dimethyl-7-aryl alkyl-1H-purine-2,6(3H,7H)-diones and a number of carbonyl containing reagents.
Methods. A nucleophilic addition reaction followed by dehydration or ethanol splitting was used, as well as the complex of the modern analysis methods to confirm the structure and individuality of the synthesized substances. Results. Different directions of 8-hydrazinyl-1,3,-dimethyl-7(fenetyl-, 3-phenylpropyl-, 3-phenylalyl)- lH-purine-2,6(3H,7H)-diones chemical transformations in reactions with the appropriate carbonyl containing compounds have been studied experimentally. The structure of synthesized substances was confirmed by chromatog-raphy/mass and 1H NMR spectroscopy.
Conclusion. The group of 7-arylalkyl-8-(3,5-R,R1-pyrazole-1-yl)theophyllines, consisting of two functionally substituted bioactive heterocycles, has been synthesized by reaction between initial substances and selected mono- and dicarbonyl compounds
Keywords: synthesis, 7,8-disubstituted of 1,3-dimethylxantine, hydrazine derivatives, spectral analysis methods
Функцюнальт noxidHi гiдразину набули широкого застосування в медичнш практицi як лiкарськi засоби для фармакокорекцП депресш, iнфекцiйниx уражень, запальних nрoцесiв, гinертензивниx статв, цукро-вого дiабету тощо. Варто зазначити, що серед вже одержаних 7-R-8-гiдразинonoxiдниx 1,3-диметилксантину також iдентифiкoванi перспективы у фармакoлoгiчнoму вiднoшеннi субстанци. Осюльки з лiтератури вiдoмo лише про спорадичн дoслiдження взаемодИ 7-R-8-гiдразинoтеoфiлiнiв з моно- та дикарбонтьними сполуками, використання тших кетовмсних реагентiв з метою функцioналiзацii 8 положення ксантинового бщиклу дозволить не ттьки вивчити синтетичний потен^ал останнього, але може з високою вирoгiднiстю призвести до одержання нових бioлoгiчнo активнихречовин. Мета. До^дити напрямки взаемодИ 8-гiдразинiл-1,3-диметил-7-арилалкiл-1H-nурин-2,6(3H,7H)-дioнiв з рядом карбоншвмкних реагентiв.
Методи. Використано реакцт нуклеофшьного приеднання з наступною дегiдратацiею чи вiдщеnленням етанолу, а також комплекс сучасних спектральних метoдiв анал1зу для тдтвердження структури й iндивiдуальнoстi синтезованих речовин.
Результати. Експериментально встанoвленi oкремi напрямки xiмiчниx перетворень 8^дразитл-1,3-диметил-7-(фенетил-, 3-фетлпротл-, 3-фенiлалiл)-1H-nурин-2,6(3H,7H)-дioнiв в реакцiяx з вiдnoвiдними карботлвмкними сполуками. Структуру синтезованих речовин тдтверджено даними хромато-мас-та 1Н ЯМР-сnектрiв.
Висновки. Ряд 7-арилалюл-8-(3,5^Дгтразол-1-ш)теофШтв, що складаються з двох функцюнально-замщених бioактивниx гетерoциклiв, синтезоваш шляхом взаемодИ виxiдниx речовин з окремими пред-ставниками моно- та дикарбоншьних сполук
Ключовi слова: синтез, 7,8-дизамiщенi 1,3-диметилксантину, noxiднi гiдразину, сnектральнi методи аналiзу
1. Introduction
Hydrazine functional derivatives are widely used in medical practice as remedies applied for pharma-cotherapy of depression, infection diseases, hypertension, diabetes, etc [1-3]. Leading scientific journals constantly show new publications displaying results of both research in the area of hydrazine containing substances synthesis, and biological study for detection of original substances with promising pharmacological effects in the given group of compounds [4, 5]. It is worth mentioning that theophylline molecule is also pharmacologically active. Its combination with different substituents, including heterocyclic number, may lead to increasing of both the severity and range of biological effects of the synthesized compounds. In this respect, a significant attention of scientists from different countries [6-8] is drawn to some 7-R-8-hydrazine derivatives of 1,3-dimethylxanthine, as basic structures for different chemical transformations.
2. Formulation of the problem in a general way, the relevance of the theme and its connection with important scientific and practical issues
Despite the large number of registered in Ukraine remedies, the need of original substances for treatment of different disorders of human's organism remains relevant. Therefore, the synthesis of new molecules (including different azaheterocycles derivatives) based on the use of already established «structure-activity» relationship is highly important for modern pharmaceutical and medical chemistry.
3. Analysis of recent studies and publications in which a solution of the problem and which draws on the author
Literature sources [2, 3] describe a pronounced biological activity of the relevant xanthine and pyrazole methylated derivatives. Some representatives of these compounds have been successfully used in medical practice, but their synthetic and pharmacological potentials are far from being exhausted.
4. Allocation of unsolved parts of the general problem, which is dedicated to the article
Considering the theophylline derivatives' high reaction ability and versatile biological activity, the synthesis of the number of original 7,8-disubstituted of 1,3-dimethylxantine was reasonable.
5. Formulation of goals (tasks) of Article
For this purpose, the reaction between investigated 8-hydrazinyl-1,3-dimethyl-7-arylalkyl-1H-purine-2,6(3H, 7H)-diones with a number of carbonyl containing reagents has been studied.
6. Statement of the basic material of the study (methods and objects) with the justification of the results
The initial 8-hydrazinyl-1,3,-dimethyl-7(fenetyl-, 3-phenylpropyl-, 3-phenylalyl)- 1H-purine-2,6(3H,7H)-diones 5-7 have been produced with high output at hydrazinolysis of 7-arylalkyl-8-bromotheophyllines 2-4, which, in turn, have been synthesized by 8-bromotheophylline 1 alkylation by (2-bromoethyl)benzene, (3-chloropropyl)benzene, and (3-chlorprop-1-enyl)benzene in dimethylformamide medium in the presence of equimolecular proportion of sodium hydrogen carbonate [9].
The reaction of 5-7 compounds with methyl 4-(4-methyl-(metoxy-,chloro-)phenyl)-2,4-dioxobutanoate and ethyl 3-(furan-2-yl)-3-oxopropanoate has been studied under different conditions of chemical process. The given reagents have not been chosen randomly, since they contain functional components, which adding to other heterocyclic systems led to strengthening of pharmacological activity of the last ones [10].
Literature sources [11, 12] show that 8-hydrazine xanthine methylized derivatives react with acetyl- and benzoyl acetone at boiling in glacial acetic acid medium with formation of appropriate 8-(3,5-R,Ri-pyrazole-1-yl)xantines.
However, in the case of the use of above mentioned esters as reagents, as results of analysis of the Re-axys Elsevier database relevant part show, reaction with 5-7 substances by the given method can be accompanied by the formation of a complex mixture of products.
It was found by experimental research, that the synthesis of methyl 3-(4-methylphenyl)-2-(2-(1,3-dimethyl-2,6-dioxo-7-phenethyl-2,3,6,7-tetrahydro-1^-purine-8-yl)hyd-razono)propanoate 8 and methyl 3-(4-chlorophenyl)-2-(2-(1,3 -dimethyl-2,6-dioxo-7-(3 -phenylalyl)-2,3,6,7-tetrahy-dro-№purine-8-yl) hydrazono)propanoate 9 happens within 48 hours at room temperature in ethanol medium in the presence of catalytic amounts of hydrochloric acid (A, Fig. 1, Table 1) (it should be noted that reducing the reaction time leads to a reduction of target products output). Under the given conditions the formation of B and C structures is impossible, which is confirmed by chromatography/mass and 1H NMR spectra (Fig. 1, Table 2).
«1 «2
•N\ Дч Дч
N N M '
О
Л
А
O^ N N N
\
Б
N R
NH2
О
А
N N N
I H
D
N R
O^ N N N
H
8,9
R — CH2-C6H5 , CH2-CH2-C6Hg, CH^ÜH-CjHJ j
onr
R, = COOCH3, —|j-"l ; R2 = C,JH4-CH3-4 , C6H4-OCH3^l, C^-Cl-4 , OH.
Fig. 1. Possible ways of reactions of the initial substances with mono- and dicarbonyle reagents
Condensation product of
8-hydrazynil-7-(phenethyl, 3 -phenylpropyl, 3 -phenylalyl)-1,3-dimethyl- 1^-purine-2,6(3^,7^)-dione
Carbonyl mix of substances O O
Table 1
No of compounds R Ri R2 Yield, % Т. pl., °С Empirical Formula
8 СН2-С6Н5 - С6Н4-СН3-4 94 175-177 C27H28N6O5
9 СН=СН-СбН5 - С6Н4-С1-4 91 189-191 C27H25CIN6O5
10 СН2-С6Н5 СООСН3 С6Н4-СН3-4 93 197-199 C27H26N6O4
11 СН2-СН2-С6Н5 СООСН3 С6Н4-СН3-4 95 168-170 C28H28N6O4
12 СН=СН-СбН5 СООСН3 С6Н4-СН3-4 91 157-159 C28H26N6O4
13 СН2-С6Н5 СООСН3 С6Н4-ОСН3-4 78 184-186 C27H26N6O5
14 СН2-СН2-С6Н5 СООСН3 С6Н4-ОСН3-4 92 149-151 C28H28N6O5
15 СН=СН-СбН5 СООСН3 С6Н4-ОСН3-4 87 95-97 C28H26N6O5
16 СН2-С6Н5 СООСН3 С6Н4-С1-4 87 157-159 C26H23C1N6O4
17 СН2-СН2-С6Н5 СООСН3 С6Н4-С1-4 94 166-168 C27H25C1N6O4
18 СН=СН-С6Н5 СООСН3 С6Н4-С1-4 93 167-169 C27H23C1N6O4
19 СН2-С6Н5 ОН 86 172-174 C22H20N6O4
20 СН2-СН2-С6Н5 ОН 85 182-183,5 C23H22N6O4
21 СН=СН-С6Н5 ОН 84 191-193 C23H20N6O4
Table 2
The results of :H NMR spectroscopic analysis of a number of original 7,8-disubstituted theophylline
10-21
The values of the chemical shift, ppm
№ Compound n7-r N1-CH3, N3-CH3 (3Н, s) R1 R2 Other protons
1 2 3 4 5 6 7
1 8 4,75t (2Н, J=7,5, ^-СН2-); 3,09t (2Н, J=6,7, -СЯ2-С6Н5); 7,45-7,27m (5Н, СН-arom.) 3,36; 3,23 3,88s (3Н, -О-СНз) 7,25-7,12m (4Н, СН-arom.); 2,26s (3H, -СН3) 7,91s (1H, -NH-); 2,41s (2H, =C(RI)-C^2-)
2 9 5,16d (2Н, J=6,3, N'-СНг-); 6,41m (1Н, -СН2-СН=); 6,61d (1Н, J=15,8, -СН=СН-); 7,38-7,29m (5Н, СН-arom.) 3,33; 3,17 3,86s (3Н, -О-СН3) 7,65-7,57m (4Н, СН-arom.) 8,04s (1H, -NH-); 3,15s (2H, =C(Ri)-CH2-)
3. 10 4,19t (2Н, J=7,2, N7-CH2-); 2,89t (2Н, J=7,0, -СН2-С6Н5); 7,21-7,13m (5Н, СН-arom.) 3,32; 3,28 3,92s (3Н, -О-СН3) 7,23d (2Н, J=7,9, С2Н-, С6H-arom.); 7,09d (2Н, J=7,7, С3Н-, СН-arom.); 2,29s (3H, -СН3) 7,32s (1H, CH-pyraz.)
4 11 3,87t (2Н, J=7,7, N'-СЯг-); 1,76t (2Н, J=7,2, -СН2-СН2-); 2,42t (2Н, J=7,4, -СН2-СН2-); 7,20m (2Н, С3Н-, СН-arom.); 7,17d (2Н, J=7,9, С2Н-, CW-arom.); 7,13d (1Н, J=8,3, C4H-arom.) 3,37; 3,25 3,90s (3Н, -О-СН3) 7,20m (2Н, С2Н-, С6H-arom.); 6,97d (2Н, J=8,1, С3Н-, СН-arom.); 2,27s (3H, -СН3) 7,27s (1H, CH-pyraz.)
5 12 4,77d (2Н, J=6,6, N7-CH2-); 5,99m (1Н, -СН2-СН=); 6,26d (1Н, J=16,2, -СН=СН-); 7,25-7,20d (3Н, J=7,7, СН-arom.); 7,16d (2Н, J=7,8, С3Н-, СН-arom.) 3,39; 3,26 3,86s (3Н, -О-СН3) 7,27d (2Н, J=7,6, С2Н-, С6H-arom.); 7,14d (2Н, J=7,8, С3Н-, СН-arom.); 2,24s (3H, -СН3) 7,29s (1H, CH-pyraz.)
6 13 4,19t (2Н, J=7,4, N7-^-); 2,89t (2Н, J=7,2, -СН2-С6Н5); 7,21-7,13m (3Н, СН-arom.); 7,08d (2Н, J=7,7, С3Н-, СН-arom.) 3,33; 3,28 3,91s (3Н, -О-СН3) 7,23d (2Н, J=8,3, С2Н-, CH-arom.); 6,92d (2Н, J=8,5, С3Н-, СН-arom.); 3,74s (3Н, -О-СН3) 7,28s (1H, CH-pyraz.)
7 14 3,87n.r.t (2Н, N7-СH2-); 1,77t (2Н, J=7,1, -СН2-СН2-); 2,43t (2Н, J=7,2, -СН2-СН2-); 7,20-7,10m (3Н, СН-arom.); 6,97d (2Н, J=7,7, С3Н-, СН-arom.) 3,38; 3,25 3,90s (3Н, -О-СН3) 7,23d (2Н, J=8,1, С2Н-, C6H-arom.); 6,94d (2Н, J=8,3, С3Н-, СН-arom.); 3,74s (3Н, -О-СН3) 7,26s (1H, CH-pyraz.)
8 15 4,77d (2Н, J=6,8, N7-СH2-); 6,00m (1Н, -СН2-СН=); 6,26d (1Н, J=16,0, -СН=СН-); 7,28-7,19m (3Н, СН-arom.); 7,15d (2Н, J=8,1, С3Н-, СН-arom.) 3,39; 3,26 3,85s (3Н, -О-СН3) 7,28-7,19m (2Н, С2Н-, C6H-arom.); 6,89d (2Н, J=8,4, С3Н-, СН-arom.); 3,70s (3Н, -О-СН3) 7,30s (1H, CH-pyraz.)
9 16 4,32t (2Н, J=7,2, N7-СH2-); 3,01t (2Н, J=7,0, -СН2-С6Н5); 7,30-7,09m (5Н, СН-arom.) 3,33; 3,27 3,93s (3Н, -О-СН3) 7,42m (2Н, С2Н-, C6H-arom.); 7,30-7,09m (2Н, С3Н-, СН-arom.) 7,42m (1H, CH-pyraz.)
1 2 3 4 5 6 7
10 17 3,96t (2Н, J=7,3, N'-СЯг-); 1,85t (2Н, J=7,0, -СЯ2-СН2-); 2,45n.r.t (2Н, -CH2-CH2-); 7,22-7,10m (3Н, CH-arom.); 7,00d (2Н, J=7,6, C2H-, C6H-arom.) 3,34; 3,25 3,91s (3Н, -О-СН3) 7,47d (2Н, J=7,9, C2H-, C6H-arom.); 7,35d (2Н, J=8,1, C3H-, С5Н-аром.) 7,38s (1Н, CH-pyraz.)
11 18 4,85d (2Н, J=6,5, N'-CHr); 6,09m (1Н, -CH2-CH=); 6,29d (1Н, J=15,8, -CH=CH-); 7,30-7,22m (3Н, CH-arom.); 7,17d (2Н, J=7,7, C2H-, C6H-arom.) 3,36; 3,27 3,87s (3Н, -О-СН3) 7,38d (2Н, J=8,1, C2H-, C6H-arom.); 7,36d (2Н, J=8,3, C3H-, C5H-arom.) 7,39s (1Н, CH-pyraz.)
12 19 4,38t (2Н, J=7,2, N7-CH2-); 3,05t (2Н, J=7,0, -CH2-C6H5); 7,28-7,12m (5Н, CH-arom.) 3,45; 3,27 7,80n.r.d (1Н, C5H-fur.); 6,89n.r.d (1Н, C4H-fur.); 6,64cn.r.d (1Н, C3H-fur.) 12,40s (1Н, -ОН) 5,88s (1Н, CH-pyraz.)
13 20 4,19t (2Н, J=6,8, N7-CH2-); 2,02t (2Н, J=6,6, -СН2-СН2-); 2,54n.r.t (2Н, -CH2-CH2-); 7,13d (2Н, J=8,1, C3H-, C5H-arom.); 7,08m (3Н, CH-arom.) 3,42; 3,26 7,76n.r.d (1Н, C5H-fur.); 6,84n.r.d (1Н, C4H-fur.); 6,61n.r.d (1Н, C3H-fur.) 12,38s (1Н, -ОН) 5,84s (1Н, CH-pyraz.)
14 21 5,03d (2Н, J=6,7, N7-CH2-); 6,32m (2Н, -CH=CH-); 7,25m (5Н, CH-arom.) 3,41; 3,24 7,75n.r.d (1Н, C5H-fur.); 6,86n.r.d (1Н, C4H-fur.); 6,57n.r.d (1Н, C3H-fur.) 12,39s (1Н, -ОН) 5,85s (1Н, CH-pyraz.)
Results of the study of reaction between 5-7 compounds and ethyl 3-(furane-2-yl)-3-oxopropanoate occurred to be interesting. Usually, heating of hydrazine derivatives with the given type of dicarbonile compounds for 1-3 hours in alcohol medium under acid catalysis conditions is realized by formation of the appropriate esters of hydrazono-3-^-propanoic acids [10, 13]. Nevertheless, in all cases there were selected from the reaction mixtures that type of products, which were identified as 8-(3-furane-2-yl)-5-hydroxy-1H-pyrazole-1-yl)-1,3-dime-thyl-7-(fenetyl-, 3-phenylpropyl-, 3-phenylalyl)- 1H-pu-rine-2,6(3H,7H)-diones 19-21 (D, Fig. 1, Table 1). Chro-matography/mass and NMR spectra completely correlate with the proposed structure D (Fig. 1, Table 2).
To implement the plan of synthetic studies, reaction between 5-7 substances and methyl 4-(4-methyl-(metoxy-, chloro-)phenyl)-2,4-dioxobutanoate) has been studied. Theoretically, formation of five products (A-E, Fig. 1) is possible in the given reaction under various conditions (medium used, duration of transformation, temperature, etc.). It has been shown, that boiling for 8 hours of the mixture components in glacial acetic acid medium may lead to cyclocondensation and production of relevant pyrazole derivatives with high output 10-18 (Fig. 1, Tab. 1) of the D structure, which is confirmed by spectral analysis results (Tab. 2). The synthesized substances (8-21) are white (8, 10-14, 16-18), greenish-yellow (9), pale brown (15, 19-21), insoluble in water, soluble in alcohols, dioxane, dimethylformamide.
Chromatography/mass spectroscopy research of 8-21 compounds under «soft» ionization conditions allowed to register appropriate peaks of quasi molecular ions [MH]+ of high intensity.
IR-spectra of 11, 12, 14, 17, 18, 20 compounds are characterized by intensive absorption of ester group of pyrazolile residue at 1742,9-1730,8 sm-1 (except 20), the same absorption lines of xanthine fragment CO-groups of molecules at 1708,7-1706,7 sm-1 and 1672,21651,9 sm-1, respectively, stretching vibrations of aromatic CH-connections as low intense lines 3137,63021,6 sm-1. For 20 substance absorption lines at 3152,0 sm-1 and 1555,9 sm-1 and intense deformation vibrations at 741,2 sm-1 were registered, which is caused by the presence of furane cycle in its structure and completely correlated with literature [14].
The analysis of :H NMR spectra of the synthesized compounds 8-21 allowed proofing their structure clearly. For 8 and 9 substances one proton singlets at 8,04-7,91 ppm and 3,15-2,41 ppm were specific, due to the presence of -NH- and -CH2-groups for substituent in the 8th position of molecules, respectively. In :H NMR spectra of 10-21 compounds pyrazole residue proton resonates as singlet at 7,42-5,84 ppm, and its chemical shift depends on the Ri and R2 radicals. Three one proton unsplit doublets, resonating at 7,80-7,75 ppm, 6,896,84 ppm and 6,64-6,57 ppm, respectively, were specific for substances 19-21, that allows to identify furane fragments of molecule [15].
In 1H NMR spectra of compounds 8 and 9 double signals of protons of -NH-, -CH2- Ta -OCH3-groups were registered, indicating possible existence of these substances as mixtures of E- and Z-isomers. Due to OH-group presence, in weak fields of 1H NMR spectra of 1921 compounds expanded one proton singlets were identified, which confirmes the presence of the given compounds in enol form.
Chromatography/mass spectroscopy research of the obtained substances were carried out using HPLC Agilent 1100 Series, equipped with diode matrix and mass-selective Agilent LC/MSD SL detectors. Chemical ionization at atmospheric pressure was chosen as ionisation method. The 1H NMR spectra of synthesized compounds were recorded by using Varian Mercury 400 (400 MHz) spectrometer, DMSO-d6 solvent, internal standard - tetrametylsylan. IR spetra (in area of 4000-600 sm-1) were recorded by using Bruker ALPHA FT-IR spectrometer on the ATR console (soothing a general display).
8-hydrazynyl-7-phenethyl-(5), 3-phenylpropyl-(6), 3-phenylalyl-(7))-1,3-dimethyl-1H-purine-2,6(3H, 7H)-diones
Add 2.43 ml hydrazine hydrate (0,05 mole at p= = 1,03 g/sm3) to 3.63 g (0.01 mole) substance 2 (to 3.77 g (0.01 mole) substance 3 or to 3.75 g (0.01 mole) substance 4) in 18 ml of the dioxane-water mixture 2:1. The obtained mixtures are heated for 4-5 hours. As soon as it cooled forcibly, yellowish or orange solutions are poured into water. Crystal precipitates are formed immediately; they are filtered and purified for the analysis by recrystal-lization from propanol-2 (5), and mixtures of ethanol-water 2:1 (6), ethanol-dioxane 5:1 (7).
Methyl 3-(4-methylphenyl-(8), 4-chlorophenyl-(9))-2-(2-(1,3-dimethyl-2,6-dioxo-7-(phenethyl-(8), 3-phenylalyl-(9))-2,3,6,7-tetrahydro-1H-purine-8-yl)hydrazono)propano-aty (Table 1)
The mixture of 0.002 mole of substance 5 or 7, 0.002 mole of methyl 4-(4-methyl-(chlorophenyl)-2,4-dioxobutanoate and 2 drops of hydrochloric acid in 15 ml of ethanol is set aside at room temperature for 48 hours. Flasks content is diluted with water; formed precipitates are filtered, dried, and recrystallized from ethanol.
Methyl 1-(1,3-dimethyl-2,6-dioxo-7-arylalkyl-2,3,6,7-tetrahydro-1H-purine-8-yl)-5-(4-R-phenyl)-1H-pirazole-33-carboxylaty (10-18, Table 1).
Add 0.0027 mole of relevant methyl 2,4-dioxo-4-R-phenylbutanoate (R=CH3, OCH3, Cl) to suspension of 0.0027 mole of substances 5-7 in 7 ml of glacial acetic acid and boil for 8 hours. Obtained solutions with intensive colors are cooled and poured into water. Formed precipitates are filtered, dried, and purified by recrystalli-zation from ethanol.
8-(3-(Furane-2-yl)-5-hydroxy-1H-pyrazole-1-yl)-1, 3-dithyl-7-(phenethyl-(19), 3-phenylpropyl-(20), 3-pheny-lalyl-(21))-1H-purine-2,6(3H,7H)-diones (Table 1).
Add 0,365 g (0.002 mole) (0.40 g (0.0022 mole)) ethyl-3-(furane-2-yl)-oxopropanoate and 2 drops of hydrochloric acid to 0.63 g (0.002 mole) of substance 5 (0,72 g (0.0022 mole) of substances 6 or 7) in 10-12 ml of propanol. Obtained mixtures are heated for 2 hours. As soon as flasks content is cooled, it should be poured into water. Precipitates of 19-21 substances that formed, are filtered, and purified for the analysis by crystallization from ethanol.
7. Conclusion
Different directions of 8-hydrazinyl-1,3,-dime-thyl-7(fenetyl-, 3-phenylpropyl, 3-phenylalyl)- 1H-puri-ne-2,6(3H,7H)-diones chemical transformations in reac-
tions with the appropriate carbonyl containing compounds have been studied experimentally. The structure of synthesized substances was confirmed by the complex of modern spectral analysis methods. The obtained 7-arylalkyl-8-(3,5- ,R,^rpyrazole-1-yl)theophyllines, consisting of two functionally substituted bioactive heterocycles, are promising enough for the further biological research.
References
1. Zelenin, K. N. Gidrazin [Text] / K. N. Zelenin // Soro-sovskij obrazovatel'nyj zhurnal. - 1998. - Vol. 5. - P. 59-65.
2. Mashkovskij, M. D. Lekarstvennye sredstva [Text] / M. D. Mashkovskij; 16th edition. - Moscow: Novaja volna, 2012. - 1216 p.
3. Martindale: The Complete Drug Reference [Text] / S. C. Sweetman (Ed.); Thirty-sixth edition. - Pharmaceutical Press, 2009. - 3694 p.
4. Rollas, S. Biological Activities of Hydrazone Derivatives [Text] / S. Rollas, S. Güniz Küfükgüzel // Molecules. -2007. - Vol. 12, Issue 8. - P. 1910-1939. doi: 10.3390/12081910
5. Narang, R. Review on Biological Activities and Chemical Synthesis of Hydrazide Derivatives [Text] / R. Narang, B. Narasimhan, S. A. Sharma // Current Medicinal Chemistry. - 2012. - Vol. 19, Issue 4. - P. 569-612. doi: 10.2174/092986712798918789
6. Mosselhi, M. A. N. New [e]-Fused Caffeines: A Simple Synthesis of 3-Substituted [1,2,4]Triazolo[4,3- e ]pu-rines [Text] / M. A. N. Mosselhi, N. M. Tawfik, A. S. Shawali // Monatshefte fur Chemie/Chemical Monthly. - 2003. -Vol. 134, Issue 4. - P. 565-571. doi: 10.1007/s00706-002-0514-7
7. Petch, D. Design and synthesis of EGFR dimeriza-tion inhibitors and evaluation of their potential in the treatment of psoriasis [Text] / D. Petch, R. J. Anderson, A. Cunningham, S. E. George, D. E. Hibbs, R. Liu et. al. // Bioorganic and Medicinal Chemistry. - 2012. - Vol. 20, Issue 19. - P. 5901-5914. doi: 10.1016/j.bmc.2012.07.048
8. Ashour, F. A. Synthesis, anticancer, anti-HIV-1, and antimicrobial activity of some tricyclic triazino and tria-zolo[4,3-e]purine derivatives [Text] / F. A. Ashour, S. M. Rida, S. A. M. El-Hawash, M. M. El-Semary, M. H. Badr // Medicinal Chemistry Research. - 2102. - Vol. 21, Issue 7. - P. 11071119. doi: 10.1007/s00044-011 -9612-6
9. Korobko, D. B. Syntez i fizyko-himichni vlastyvosti dejakyh 7-aralkil-(alkenil)-8-bromo-(tio-)teofiliniv [Text]: ma-terialy XXVIII vseukr. naukovo-prakt. konf. / D. B. Korobko, O. V. Berezovs'kyj, M. M. Palagnjuk, Je. S. Pylypiv // Liky -ljudyni. - Harkiv, 2011. - P. 263-269.
10. Abdel-Wahab, B. F. Utility of 2,4-dioxoesters in the synthesis of new heterocycles [Text] / B. F. Abdel-Wahab,
H. Abdel-Gawad, H. A. Mohamed, K. M. Dawood // HETER-OCYCLES. - 2010. - Vol. 81, Issue 1. - P. 1-55. doi: 10.3987/ rev-09-659
11. Gumennoj, V. P. Kondensacija 1,3-dikarbonil'nyh soedinenij s 8-gidrazinoksantinami [Text] / V. P. Gumennoj // Chem. Abstrac. - 1984. - Vol. 101, Issue 13. - P. 110869.
12. Povstjanoj, M. V. Kondensirovannye imidazo-
I,2,4-aziny. XXVI. O reakcii 8-gidrazinoksantina i 8-(1-metilgidrazino)teofillina s acetil- i benzoilacetonom [Text] / M. V. Povstjanoj, V. P. Kruglenko, N. A. Kljuev et. al. // Zhurnal org. himii. - 1992. - Vol. 28, Issue 4. - P. 849-856.
13. Voskobojnik, O. Ju. Syntez, peretvorennja, fizyko-himichni ta biologichni vlastyvosti [{2-R-(3H)-[hinazolin-4-iliden}gidrazono]karbonovyh kyslot [Text]: avtoref. dys. ... kand. farm. nauk : spec. / O. Ju. Voskobojnik. - L'viv. nac. med. un-t imeni Danyla Galyc'kogo, 2008. - 26 p.
14. Tarasevich, B. N. IK spektry osnovnyh klassov or-ganicheskih soedinenij. Spravochnye materialy [Text] / B. N. Tarasevich. - Moscow: MGU, 2012. - 55 p.
15. Silverstein, R. M. Spectrometric identification of organic compounds. 7 edition [Text] / R. M. Silverstein, F. X. Webster, D. J. Kiemle. - John Wiley & Sons Ltd, USA, 2005. - 267 p.
References
1. Zelenin, K. N. (1998). Gidrazin. Sorosovskij obra-zovatel'nyj zhurnal, 5, 59-65.
2. Mashkovskij, M. D. (2012). Lekarstvennye sredstva. 16th edition. Moscow: Novaja volna, 1216.
3. Sweetman, S. C. (Ed.) (2009). Martindale: The Complete Drug Reference. Thirty-sixth edition. Pharmaceutical Press, 3694.
4. Rollas, S., Kujukguzel, S. G. (2007). Biological Activities of Hydrazone Derivatives. Molecules, 12 (8), 19101939. doi: 10.3390/12081910
5. Narang, R., Narasimhan, B., Sharma, S. (2012). A Review on Biological Activities and Chemical Synthesis of Hy-drazide Derivatives. Current Medicinal Chemistry, 19 (4), 569612. doi: 10.2174/092986712798918789
6. Mosselhi, M. A. N., Tawfik, N. M., Shawali, A. S. (2003). New [ e ]-Fused Caffeines: A Simple Synthesis of 3-Substituted [1,2,4]Triazolo[4,3- e ]purines. Monatshefte Fur Chemie/Chemical Monthly, 134 (4), 565-571. doi: 10.1007/ s00706-002-0514-7
7. Petch, D., Anderson, R. J., Cunningham, A., George, S. E., Hibbs, D. E., Liu, R. et. al. (2012). Design and synthesis of EGFR dimerization inhibitors and evaluation of their potential in the treatment of psoriasis. Bioorganic &
Medicinal Chemistry, 20 (19), 5901-5914. doi: 10.1016/ j.bmc.2012.07.048
8. Ashour, F. A., Rida, S. M., El-Hawash, S. A. M., ElSemary, M. M., Badr, M. H. (2011). Synthesis, anticancer, anti-HIV-1, and antimicrobial activity of some tricyclic triazino and triazolo[4,3-e]purine derivatives. Medicinal Chemistry Research, 21 (7), 1107-1119. doi: 10.1007/s00044-011-9612-6
9. Korobko, D. B., Berezovs'kyj, O. V., Palagnjuk, M. M., Pylypiv, Je. S. (2011). Syntez i fizyko-himichni vlastyvosti de-jakyh 7-aralkil-(alkenil)-8-bromo-(tio-)teofiliniv. Liky - lju-dyni. Harkiv, 263-269.
10. Abdel-Wahab, B. F., Abdel-Gawad, H., Mohamed, H. A., Dawood, K. M. (2010). Utility of 2,4-Dioxoesters in the Synthesis of New Heterocycles. HETEROCYCLES, 81 (1), 1-55. doi: 10.3987/rev-09-659
11. Gumennoj, V. P. (1984). Kondensacija 1,3-dika-rbonil'nyh soedinenij s 8-gidrazinoksantinami. Chem. Abstrac., 101 (13), 110869.
12. Povstjanoj, M. V., Kruglenko, V. P., Kljuev, N. A. et. al. (1992). Kondensirovannye imidazo-1,2,4-aziny. XXVI. O reakcii 8-gidrazinoksantina i 8-(1-metilgidrazino)teofillina s acetil- i benzoilacetonom. Zhurnal org. himii, 28 (4), 849-856.
13. Voskobojnik, O. Ju. (2008). Syntez, peretvorennja, fizyko-himichni ta biologichni vlastyvosti [{2-R-(3H)-[hina-zolin-4-iliden}gidrazono]karbonovyh kyslot. L'viv. nac. med. un-t imeni Danyla Galyc'kogo, 26.
14. Tarasevich, B. N. (2012). IK spektry osnovnyh klassov organicheskih soedinenij. Spravochnye materialy. Moscow: MGU, 55.
15. Silverstein, R. M., Webster, F. X., Kiemle, D. J. (2005). Spectrometric identification of organic compounds. 7 edition. John Wiley & Sons Ltd, USA, 267.
Рекомендовано до публгкацИ д-р фарм. наук, професор Коваленко С. I.
Дата надходженнярукопису 09.02.2016
Korobko Dmytro, Candidate of Pharmaceutical Sciences, Associate Professor, Department of Pharmaceutical Chemistry. Dean of Pharmaceutical Faculty, I. Horbachevsky Ternopil State Medical University, 36 Ruska str., Ternopil, Ukraine, 46001 E-mail: kodibo.kdb@mail.ru
